MCQs on Biotechnology and its Applications: Class-XII for NEET Practice
This Page Score: 0/40
Match the organisms in List-I with their characteristic biotechnological utility in List-II:
List-I (Organism)
List-II (Utility/Product)
A. *Bacillus thuringiensis*
P. Source of the insecticidal protein toxin
B. *E. coli*
Q. Used to produce separate A and B chains of insulin
C. Transgenic Mice
R. Used in toxicity/chemical safety testing
D. Transgenic Cow (Rosie)
S. Produced human protein-enriched milk
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. *Bacillus thuringiensis* is the source of the Bt toxin gene, used to create bio-pesticides. B. *E. coli* plasmids were used by Eli Lilly to produce the A and B chains of human insulin separately. C. Transgenic mice are used extensively for toxicity/chemical safety testing. D. Rosie, the first transgenic cow, produced human alpha-lactalbumin enriched milk.
Match the GM crop benefits in List-I with their context in List-II:
List-I (GM Benefit)
List-II (Related Feature)
A. Post-harvest losses
P. Reduced by genetic modification
B. Starches/Fuels/Pharmaceuticals
Q. Alternative resources supplied by tailor-made GM plants
C. Increased Yields
R. Due to improved varieties and better management (Green Revolution)
D. Insect resistance
S. Provided by cloning and expressing Bt toxin gene in plants
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. Genetic modification has helped to reduce post harvest losses. B. GM has been used to create tailor-made plants to supply alternative resources like starches, fuels, and pharmaceuticals to industries. C. Increased yields during the Green Revolution were partly due to improved crop varieties and better management. D. Cloning and expressing the Bt toxin gene in plants provides resistance to insects.
Match the molecular diagnosis elements in List-I with their function/result in List-II:
List-I (Element)
List-II (Function/Result)
A. Radioactive Probe
P. Tags single-stranded DNA or RNA molecule
B. Mutated Gene Clone
Q. Will not appear on the photographic film
C. Autoradiography
R. Detection method following probe hybridisation
D. Pathogen Concentration (high)
S. Condition when disease symptoms are produced
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. A radioactive probe is a single stranded DNA or RNA molecule tagged with a radioactive molecule. B. The clone having the mutated gene will not appear on the photographic film because the probe will not have complementarity. C. Detection of hybridised probes is performed using autoradiography. D. Disease symptoms appear only when the concentration of the pathogen is already very high in the body.
Match the insect groups in List-I with their characteristic pest examples in List-II:
List-I (Insect Order)
List-II (Example Pest)
A. Lepidopterans
P. Tobacco budworm, armyworm
B. Coleopterans
Q. Beetles
C. Dipterans
R. Flies, mosquitoes
D. Corn borer
S. Controlled by *cryIAb* gene
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. Bt proteins kill Lepidopterans like tobacco budworm and armyworm. B. Bt proteins kill Coleopterans (beetles). C. Bt proteins kill Dipterans (flies, mosquitoes). D. The protein encoded by the gene *cryIAb* controls corn borer.
Match the ADA gene therapy steps/components in List-I with their description in List-II:
List-I (Component/Step)
List-II (Action/Status)
A. Non-curative treatment
P. Enzyme replacement therapy
B. Permanent cure strategy
Q. Gene introduction at early embryonic stages
C. Temporary infusion required
R. Genetically engineered lymphocytes
D. First clinical gene therapy year
S. 1990
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. Enzyme replacement therapy is not a completely curative approach for ADA deficiency. B. Introducing the gene into cells at early embryonic stages is the strategy for permanent cure. C. Genetically engineered lymphocytes require periodic infusion because they are not immortal. D. The first clinical gene therapy was given in 1990.
Match the tissue culture components in List-I with their specific role in List-II:
List-I (Component)
List-II (Role)
A. Sucrose
P. Carbon source in the nutrient medium
B. Auxins and Cytokinins
Q. Required growth regulators
C. Explant environment
R. Must be sterile conditions
D. Inorganic Salts/Vitamins
S. Essential components of nutrient medium
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. Sucrose provides the carbon source in the nutrient medium. B. Auxins and cytokinins are growth regulators required in the medium. C. Explants are grown under sterile conditions. D. The nutrient medium must provide inorganic salts, vitamins, and amino acids.
Match the Bt Toxin states and mechanisms in List-I with their description in List-II:
List-I (Mechanism)
List-II (Description)
A. Protoxin location
P. Inactive form within *Bacillus thuringiensis*
B. Toxin activation trigger
Q. Alkaline pH of the insect gut
C. Toxin action on cell membrane
R. Creation of pores leading to lysis
D. Toxin binding site
S. Surface of midgut epithelial cells
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. The Bt toxin protein exists as inactive protoxin within the bacterium *Bacillus thuringiensis*. B. The inactive toxin is converted to active form due to the alkaline pH of the insect gut. C. The creation of pores by the toxin leads to cell swelling and lysis. D. The activated toxin binds specifically to the surface of midgut epithelial cells.
Match the GM crop benefits in List-I with the corresponding outcome in List-II:
List-I (Benefit Type)
List-II (Outcome/Example)
A. Abiotic Stress Tolerance
P. More tolerant to cold, drought, salt, heat
B. Mineral Usage Efficiency
Q. Prevents early exhaustion of soil fertility
C. Nutritional Enhancement
R. Golden rice (Vitamin ‘A’ enriched)
D. Post Harvest Losses
S. Reduced by genetic modification
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. Genetic modification has made crops more tolerant to abiotic stresses (cold, drought, salt, heat). B. Increased mineral usage efficiency prevents early exhaustion of soil fertility. C. Golden rice is an example of enhanced nutritional value (Vitamin A enriched). D. Genetic modification has helped reduce post harvest losses.
Match the ethical/legal aspects in List-I with their descriptions in List-II:
List-I (Issue/Entity)
List-II (Description/Context)
A. Industrially rich nations
P. Rich financially but poor in biodiversity
B. Developing nations
Q. Rich in biodiversity and traditional knowledge
C. Basmati Rice Patent (1997)
R. Obtained through the US Patent and Trademark Office
D. Unpredictable Results
S. Risk of introducing genetically modified organisms into ecosystem
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. Industrially rich nations are financially rich but poor in biodiversity and traditional knowledge. B. Developing and underdeveloped countries are rich in biodiversity and traditional knowledge. C. The Basmati patent was granted by the US Patent and Trademark Office in 1997. D. Genetic modification of organisms can have unpredictable results when introduced into the ecosystem.
Match the usage of Transgenic Animals in List-I with their specific focus in List-II:
List-I (Usage Area)
List-II (Focus/Product)
A. Normal Physiology Study
P. Studying how genes are regulated
B. Complex Factor Study
Q. Insulin-like growth factor
C. Most Common Transgenic Animal
R. Mice (over 95 per cent of all existing transgenic animals)
D. Biological Product for Emphysema
S. Alpha-1-antitrypsin
[Biotechnology-and-its-Applications] [class-xii ]
A-P, B-Q, C-R, D-S
A-Q, B-P, C-R, D-S
A-P, B-R, C-Q, D-S
A-S, B-Q, C-R, D-P
Correct Option: A  [ A-P, B-Q, C-R, D-S ]
Remark: A. Transgenic animals are designed to study how genes are regulated and affect normal functions. B. Insulin-like growth factor is an example of a complex factor involved in growth studied using transgenic animals. C. Mice constitute over 95 per cent of all existing transgenic animals. D. Human protein alpha-1-antitrypsin is used to treat emphysema.